And in the end, the results of this research indicated that in the context of obesity-related hypertension, compensatory effects, adiponectin resistance, and decreased adiponectin clearance due to impaired renal and hepatic function occur simultaneously, contributing to the “adiponectin paradox”. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.